MBX Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $84.2M
Liabilities Breakdown FY2023
Total Liabilities: $4.3M
Asset Breakdown
Total Assets: $84.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.5M | 36.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $439.0K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $53.2M | 63.2% |
Liabilities Breakdown
Total Liabilities: $4.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 32.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.9M | 67.6% |